Valuation: Tellgen Corporation

Market Cap	2.76B 414M 369M 341M 310M 581M 39.2B 590M 4.1B 1.62B 20.54B 1.55B 1.52B 65.06B	P/E 2024	66.3x	P/E 2025	836x
Enterprise Value	2.55B 382M 341M 315M 286M 537M 36.21B 545M 3.79B 1.49B 18.97B 1.43B 1.4B 60.1B	EV / Sales 2024	4.21x	EV / Sales 2025	7.5x
Free-Float	65.03%	Yield 2024	1.06%	Yield 2025	0.54%

* Estimated data More valuation ratios

Latest news: Tellgen Corporation

08-25	Tellgen Corporation Proposes Interim Cash Dividend on A Shares for the First Half of 2026, Payable on 3 September 2026	CI
08-24	Tellgen Corporation Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-04	Tellgen Gets Chinese Provincial Level Approval for Osteoporosis Diagnostic Reagent	MT
04-26	Tellgen Corporation announces Annual dividend, payable on May 26, 2026	CI
04-24	Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-23	Tellgen Corporation agreed to acquire an additional 6.78% stake in Wuhan HealthCare Biotechnology Co., Ltd. from Chen Gang and Xie Jun for CNY 27.1 million.	CI
04-22	Tellgen Corporation announced that it expects to receive CNY 300 million in funding	CI
11-19	Tellgen Gets Chinese Regulatory Nod for Detection Kit's Expanded Use	MT
27/10/25	CytoCares Inc. announced that it has received funding from Tellgen Corporation	CI
22/10/25	Huihe Biotechnology Co., Ltd. announced that it has received CNY 68 million in funding from Tellgen Corporation	CI
22/10/25	Tellgen Corporation Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
10/10/25	Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on April 8, 2025.	CI
29/09/25	Tellgen Corporation's Equity Buyback announced on April 8, 2025, has closed with 737,000 shares, representing 0.46% for CNY 20.03 million.	CI

More news

Managers and Directors: Tellgen Corporation

Manager	Title	Age	Since
Jian Er Yao CEO	Chief Executive Officer	56	05/11/2003
Song Tao Li DFI	Director of Finance/CFO	50	08/06/2023
En Huan Yang PRN	Corporate Officer/Principal	44	31/03/2009

Director	Title	Age	Since
Jian Er Yao CHM	Chairman	56	05/11/2003
En Huan Yang BRD	Director/Board Member	44	08/12/2020
Zhang Fu Yu BRD	Director/Board Member	63	13/08/2019

More insiders

Diagnostic & Testing Substances

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TELLGEN CORPORATION	-9.56%	-7.68%	-35.29%	-4.47%	457M
ABBOTT LABORATORIES	+1.78%	-1.96%	-19.79%	+7.15%	174B
STRYKER CORPORATION	+2.69%	+4.27%	-21.27%	+16.01%	114B
MEDTRONIC PLC	+2.92%	+0.32%	-0.15%	+32.28%	114B
ESSILORLUXOTTICA	+1.93%	+19.13%	-43.11%	+7.04%	89.64B
CENCORA, INC.	-0.41%	-0.68%	+2.51%	+79.59%	64.96B
HOYA CORPORATION	-0.47%	+3.86%	+15.10%	+80.50%	56.09B
BECTON, DICKINSON AND COMPANY	+2.05%	+2.28%	+5.35%	-22.56%	52.94B
IDEXX LABORATORIES, INC.	+1.99%	+3.21%	-10.89%	+32.04%	43.6B
ALCON INC.	+3.43%	+4.93%	-5.06%	-10.80%	32.77B
Average	+0.65%	+2.78%	-11.26%	+21.68%	74.24B
Weighted average by Cap.	+1.86%	+3.57%	-12.28%	+22.78%

See all sector performances

Tellgen Corporation is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The Company's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The Company conducts its business in the domestic and overseas markets.

Employees

683

Sector

Medical Equipment, Supplies & Distribution

Calendar

10-27 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
21/10/26	CN¥17.31	-9.56%	18,474,050
21/10/26	CN¥19.14	+3.63%	20,574,260
20/10/26	CN¥18.47	-0.16%	16,752,760
19/10/26	CN¥18.50	-6.19%	21,662,900
16/10/26	CN¥19.72	+7.06%	30,023,051

End-of-day quote Shenzhen S.E.

More quotes

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tellgen Corporation

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Shenzhen S.E. 22/10/2026			5-day change	1st Jan Change
17.31 ^CNY	-9.56%		-7.68%	-5.87%

1 day	-9.56%
1 week	-7.68%
Current month	-16.94%
1 month	-14.94%
3 months	+46.82%
6 months	+2.79%
Current year	-5.87%

1 week	17.3	21.38
1 month	17.3	22.47
Current year	11.04	22.87
1 year	11.04	27.46
3 years	9.94	32.8
5 years	9.94	42.68
10 years	9.94	50.25

	2024	2025
Net sales	437M 65.43M 58.4M 53.88M 48.95M 91.83M 6.2B 93.24M 649M 256M 3.25B 246M 240M 10.29B	364M 54.5M 48.64M 44.88M 40.77M 76.49M 5.16B 77.67M 541M 213M 2.7B 205M 200M 8.57B
Net income	34.53M 5.17M 4.62M 4.26M 3.87M 7.26M 490M 7.37M 51.32M 20.22M 257M 19.42M 19M 813M	3.59M 537K 480K 443K 402K 754K 50.91M 766K 5.33M 2.1M 26.67M 2.02M 1.97M 84.49M
Net Debt	-434M -65.05M -58.06M -53.56M -48.66M -91.29M -6.16B -92.7M -645M -254M -3.23B -244M -239M -10.23B	-210M -31.51M -28.12M -25.95M -23.57M -44.22M -2.98B -44.9M -313M -123M -1.56B -118M -116M -4.95B

Tellgen Corporation Share Price

Stocks

300642

CNE100002P42

Medical Equipment, Supplies & Distribution

Valuation: Tellgen Corporation

Chart: Tellgen Corporation

Latest news: Tellgen Corporation

Quotes and Performance

Price Extremes

Managers and Directors: Tellgen Corporation

Diagnostic & Testing Substances

Financials

Company Profile

Quotes

Annual profits - Rate of surprise